Pharmacologic management of cancer pain in rural Minnesota

Journal of Pain and Symptom Management

Volumn 12, Issue 5, 1996, Pages 283-289

  Lichtblau, Leonard ^a   Belgrade, Miles ^b   Auld, Richard ^c   Elliott, Thomas E ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ABBOTT NORTHWESTERN HOSPITAL   (United States)

^c Medical Examiner Hennepin County   (United States)

^d Duluth Clinic   (United States)

Author keywords

analgesic adjuvant; Cancer pain; Cancer Pain Initiative; Minnesota community; NSAID; opioid

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; AMITRIPTYLINE; CARBAMAZEPINE; CLONAZEPAM; CODEINE; DEXAMETHASONE; DEXTROPROPOXYPHENE; DOXEPIN; DRONABINOL; ETODOLAC; FENTANYL; HYDROCODONE; HYDROMORPHONE; HYDROXYZINE; IBUPROFEN; KETOROLAC; LIDOCAINE; LORAZEPAM; METHADONE; MORPHINE; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; OXYCODONE; PARACETAMOL; PREDNISONE; SALSALATE; UNINDEXED DRUG;

ANALGESIA; ARTICLE; CANCER PAIN; DRUG CHOICE; HUMAN; ORAL DRUG ADMINISTRATION; RURAL AREA; UNITED STATES;

ANALGESICS; FEMALE; HUMANS; MALE; MINNESOTA; NEOPLASMS; PAIN; RURAL HEALTH;

EID: 0030296511     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(96)00179-0     Document Type: Article

References (18)

1. 1. Bonica JJ. Cancer pain. In: Bonica JJ, ed. The management of pain, 2nd ed, vol 1. Philadelphia: Lea and Febiger, 1990:400-414.
2. 2. Dahl JL, Joranson DE, Engber D, Dosch J. The cancer pain problem: Wisconsin's response: a report on the Wisconsin Cancer Pain Initiative. J Pain Symptom Manage 1988;3:S1-S20.
3. 3. Elliott TE, Murray DM, Oken MM, Johnson KM, Elliott BA, Post-White J. The Minnesota Cancer Pain Project: design, methods and education strategies. J Cancer Educ 1995;10:102-112.
4. 4. Physicians' Desk Reference, 48th ed, 1994. Montvale, NJ: Medical Economics Data Publishing, 1993.
5. 5. Goldberg RJ, Mor V, Wiemann M, Greer DS, Hiris J. Analgesic use in terminal cancer patients: report from the National Hospice Study. J Chron Dis 1986;39:37-45.
6. 6. Brescia FJ, Portenoy RK, Krasnoff L, Gray G. Pain, opioid use and survival in hospitalized patients with advanced cancer. J Clin Oncol 1992; 10:149-155.
7. 7. Bruera E, Fox R, Chadwick S, Brenneis C, MacDonald N. Changing patterns in the treatment of pain and other symptoms in advanced cancer patients. J Pain Symptom Manage 1987;2:139-144.
8. 8. McCormack A, Hunter-Smith D, Piotrowski ZH, Grant M, Kubik S, Kessel K. Analgesic use in home hospice cancer patients. J Fam Pract 1992;34:160-164.
9. 9. Seitz AM. Analgesic utilization patterns in a hospice. Oncology 1987;1:S33-S36.
10. 10. WHO Expert Committee. Cancer pain relief and palliative care. Technical Report Series 804. Geneva, Switzerland: World Health Organization, 1990:23-41.
11. 11. Hanks GW, Justins DM. Cancer pain: management. Lancet 1992;339:1031-1036.
12. 12. Jacox A, Carr DB, Payne R, et al. Management of cancer pain. In: Clinical practice guideline no. 9 (AHCPR publication no. 94-0592). Rockville, MD: Agency for Health Care Policy and Research, 1994: 51-65.
13. 13. Portenoy RK. Adjuvant analgesics in pain management. In: Doyle D, Hanks, GWC, MacDonald N, eds. Oxford textbook of palliative medicine. Oxford, England: Oxford Medical Publications, 1993:187-203.
14. 14. Galasko CSB. Mechanisms of bone destruction in the development of skeletal metastases. Nature 1976;263:507-510.
15. 15. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves posherpatic neuralgia. Neurology 1988;38:1427-1432.
16. 16. American Pain Society. Principles of analgesic use in the treatment of acute pain and chronic cancer pain, 3rd ed. Skokie, IL: American Pain Society, 1992.
17. 17. Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983;13:180-185.
18. 18. Foley KM. The treatment of cancer pain. N Engl J Med 1985;313:84-95.